Article
Selective Targeting of Pathological Angiogenesis via CPT2 Antagonism Mitigates Graft-versus-Host Disease
2026-06-02
Abstract excerpt
<title>Abstract</title> <p> Immunosuppressive treatments are broadly used to prevent or treat graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (alloSCT). The resulting severe treatment-related immunodeficiency is the main contributor to high alloSCT-associated mortality, highlighting the medical need for non-immunosuppressive strategies to prevent GVHD. Angiogenesis repre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4c9a3e1f-a2dd-5e00-a781-0f2c6d45ff75
- DOI
- 10.21203/rs.3.rs-9620419/v1
